Table 3.
Change from Baseline at Week 12 | Intervention | Mean Difference (95%CI) | p | |
---|---|---|---|---|
Exercise (n = 22) | Control (n = 28) | |||
Median (SE) | Median (SE) | |||
PWV, m/s | −0.26 (0.14) | −0.22 (0.13) | −0.034 (−0.42 to 0.36) | 0.860 |
hsCRP, mg/L | 0.17 (0.59) | −0.24 (0.55) | 0.411 (−1.25 to 2.07) | 0.619 |
TNF-α, pg/mL | −4.04 (1.53) | −2.49 (1.41) | −1.55 (−5.87 to 2.78) | 0.475 |
IL-6, pg/mL | −3.86 (1.04) | −5.05 (0.99) | 1.19 (−1.86 to 4.25) | 0.437 |
MPO, ng/mL | −27.84 (9.61) | −7.49 (9.02) | −20.35 (−47.38 to 6.68) | 0.136 |
Cardiorespiratory fitness (Bruce), min | 2.49 (0.44) | 0.22 (0.41) | 2.26 (0.98 to 3.55) | 0.001 |
The analyses were adjusted for baseline values, resting heart rate, and changes in self-reported physical activity during the study period. SE, standard error; CI, confidence interval; PWV, pulse wave velocity; hsCRP, high sensitivity C-reactive protein; TNF-α, tumor necrosis factor alpha; IL-6, interleukin-6; MPO, myeloperoxidase.